Yes. The only information I found on earlier testing was the following
The potential therapeutic was studied thoroughly and showed safety and efficacy in preclinical and IND-enabling studies.
https://www.cureraredisease.org/blog-posts/faq-on-the-findings-from-the-crd-tmh-001-case-report
Ann: PYC Therapeutics Investor Call - 18 August 2022, page-25
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $489.9M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.0¢ | 10.0¢ | $392.3K | 3.706M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 1506182 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 1714856 | 9 |
View Market Depth
| Last trade - 16.10pm 22/05/2024 (20 minute delay) ? |
|
|||||
|
Last
10.5¢ |
Change
0.000 ( 4.17 %) |
||||
| Open | High | Low | Volume | ||
| 10.8¢ | 11.0¢ | 10.5¢ | 1029511 | ||
| Last updated 15.58pm 22/05/2024 ? | |||||
| PYC (ASX) Chart |